Cited by 925TGF-β signaling in diseasesImmune cells in cancerChemokine receptors and signaling

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Open access

Yang, Li, Huang, Jianhua, Ren, Xiubao, Gorska, Agnieszka E., Chytil, Anna, Aakre, Mary, Carbone, David P., Matrisian, Lynn M., Richmond, Ann, Lin, P. Charles, Moses, Harold L.·2008·Cancer Cell

DOI 10.1016/j.ccr.2007.12.004PMC PMC2245859

Open this paper in CoChat — free account Open PDF

Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.12.004

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Endothelial Progenitor Cells
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,388
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citation
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,565
Self-citation
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citation
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,197
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Self-citation

Flagged first, then by citations

Show all 61 references

1 of the 61 references couldn’t be matched to a known paper.

Sorted by citations

Items 301–400 of 925

Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2
van Deventer, H. W., Palmieri, D., Wu, Q., McCook, E. C., & Serody, J. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202857 · Cited by 94
Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis
Yamamoto, T. S., Kawada, K., Itatani, Y., Inamoto, S., Okamura, R., Iwamoto, M., Miyamoto, E., Chen-Yoshikawa, T. F., Hirai, H., Hasegawa, S., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0520 · Cited by 91
Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells
Long, Y., Lu, Z., Xu, S., Li, M., Wang, X., Zhang, Z., & He, Q. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03883 · Cited by 90
Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness
Ning, J., Ye, Y., Bu, D., Zhao, G., Song, T., Liu, P., Yu, W., Wang, H., Li, H., Ren, X., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.016 · Cited by 91
Self-citation
A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression
Deng, H., Lin, C., Garcia-Gerique, L., Fu, S., Cruz, Z., Bonner, E. E., Rosenwasser, M. J., Rajagopal, S., Sadhu, M. N., Gajendran, C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4045 · Cited by 90
In Vivo Interstitial Migration of Primitive Macrophages Mediated by JNK-Matrix Metalloproteinase 13 Signaling in Response to Acute Injury
Zhang, Y., Bai, X.-T., Zhu, K.-Y., Jin, Y., Deng, M., Le, H., Fu, Y., Chen, Y., Zhu, J., Look, A. T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2155 · Cited by 90
Chemokines in tumor development and progression
Mukaida, N., & Baba, T. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.10.012 · Cited by 92
Myeloid‐Derived Suppressor Cells and Therapeutic Strategies in Cancer
Katoh, H., & Watanabe, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/159269 · Cited by 91
Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
Terabe, M., Robertson, F. C., Clark, K. T., Ravin, E. D., Bloom, A. C., Venzon, D. J., Kato, S., Mirza, A. M., & Berzofsky, J. A. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1308616 · Cited by 89
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs
Bosiljcic, M., Cederberg, R. A., Hamilton, M. J., LePard, N. E., Harbourne, B., Collier, J. L., Halvorsen, E. C., Shi, R., Franks, S. E., Kim, A. Y., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1189-x · Cited by 89
Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies
Park, K., Veena, M. S., & Shin, D. S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.830208 · Cited by 91
Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells
Liu, F., Li, X., Lu, C., Bai, A., Bielawski, J., Bielawska, A. E., Marshall, B., Schoenlein, P. V., Lebedyeva, I., & Liu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.13438 · Cited by 93
Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer
Ma, X., Wang, M., Yin, T., Zhao, Y., & Wei, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00855 · Cited by 91
Lung Metastasis Fails in MMTV-PyMT Oncomice Lacking S100A4 Due to a T-Cell Deficiency in Primary Tumors
Grum-Schwensen, B., Klingelhöfer, J., Grigorian, M., Almholt, K., Nielsen, B. S., Lukanidin, E. M., & Ambartsumian, N. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3220 · Cited by 85
CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways
Sobolik, T., Su, Y., Wells, S., Ayers, G. D., Cook, R. S., & Richmond, A. J. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0360 · Cited by 85
Self-citation
Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1−PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
Liu, M., Wei, F., Wang, J., Yu, W., Shen, M., Liu, T., Zhang, D., Wang, Y., Ren, X., & Sun, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03745-1 · Cited by 85
Self-citation
The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
Leone, K., Poggiana, C., & Zamarchi, R. (2018) · Diagnostics · doi:10.3390/diagnostics8030059 · Cited by 87
Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression?
Méndez-García, L. A., Castro, K. E. N., Ochoa-Mercado, T. D. L., Arreola, M. I. P., Ruiz‐Manzano, R. A., Mendoza, M. S., Solleiro-Villavicencio, H., Cázarez-Martínez, C., & Morales‐Montor, J. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0024 · Cited by 87
Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Kim, S., Buchlis, G., Fridlender, Z. G., Sun, J., Kapoor, V., Cheng, G., Haas, A. R., Cheung, H. K., Zhang, X., Corbley, M. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1494 · Cited by 85
Anastomotic Leakage Contributes to the Risk for Systemic Recurrence in Stage II Colorectal Cancer
Katoh, H., Yamashita, K., Wang, G., Sato, T., Nakamura, T., & Watanabe, M. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1379-4 · Cited by 85
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
Eruslanov, E. B., Kaliberov, S. A., Daurkin, I., Kaliberova, L. N., Buchsbaum, D. J., Vieweg, J., & Kusmartsev, S. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802358 · Cited by 83
Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations
Schouppe, E., BAETSELIER, P. D., Ginderachter, J. A. V., & Sarukhan, A. (2012) · OncoImmunology · doi:10.4161/onci.21566 · Cited by 83
Potential therapeutic effects of curcumin in gastric cancer
Barati, N., Momtazi‐Borojeni, A. A., Majeed, M. A., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27229 · Cited by 83
Exploring the Crosstalk between Inflammation and Epithelial‐Mesenchymal Transition in Cancer
Chattopadhyay, I., Ambati, R. R., & Gundamaraju, R. (2021) · Mediators of Inflammation · doi:10.1155/2021/9918379 · Cited by 81
CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ
Yan, H. H., Jiang, J. D., Pang, Y., Achyut, B. R., Lizardo, M. M., Liang, X., Hunter, K. W., Khanna, C., Hollander, C. M., & Li, Y. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2282-t · Cited by 83
Myeloid derived suppressor cells and their role in tolerance induction in cancer
Fujimura, T., Mahnke, K., & Enk, A. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.05.001 · Cited by 80
The immune suppressive function of transforming growth factor-β(TGF-β) in human diseases
Sheng, J., Chen, W., & Zhu, H. (2015) · Growth Factors · doi:10.3109/08977194.2015.1010645 · Cited by 85
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
Wang, B., Yin, H., Zhang, Y., Zhao, Q., Wang, H., Wei, J., Meng, L., Xin, Y., & Jiang, X. M. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01073-9 · Cited by 85
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism
Yang, F., Lee, G., & Fan, Y. (2024) · Angiogenesis · doi:10.1007/s10456-024-09913-z · Cited by 90
Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer
Takahashi, N., Iwasa, S., Sasaki, Y., Shoji, H., Honma, Y., Takashima, A., Okita, N. T., Kato, K., Hamaguchi, T., & Yamada, Y. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2184-6 · Cited by 81
Intravasation as a Key Step in Cancer Metastasis
Zavyalova, M. V., Denisov, E. V., Таширева, Л. А., Savelieva, O. E., Кайгородова, Е. В., Krakhmal, N. V., & Михайлович, П. В. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919070071 · Cited by 86
Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells
Neel, J.-C., & Lebrun, J. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.03.013 · Cited by 79
Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties
Novitskiy, S. V., Pickup, M. W., Chytil, A., Polosukhina, D., Owens, P., & Moses, H. L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211639 · Cited by 79
Self-citation
Myeloid derived suppressor cells
Waldron, T. J., Quatromoni, J. G., Karakasheva, T. A., Singhal, S. K., & Rustgi, A. K. (2013) · OncoImmunology · doi:10.4161/onci.24117 · Cited by 81
Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling
Sharif, G. M., Schmidt, M. O., Yi, C., Hu, Z., Haddad, B. R., Glasgow, E. F., Riegel, A. T., & Wellstein, A. (2015) · Oncogene · doi:10.1038/onc.2015.44 · Cited by 77
GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency
Ye, P., Chen, W., Wu, J., Huang, X., Li, J., Wang, S., Liu, Z., Wang, G., Yang, X. Y., Zhang, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67356 · Cited by 79
Myeloid‐derived suppressor cells are key players in the resolution of inflammation during a model of acute infection
Arocena, A. R., Onofrio, L. I., Pellegrini, A. V., Silva, E. A. C., Paroli, A. F., Cano, R. C., Aoki, M. P., & Gea, S. (2013) · European Journal of Immunology · doi:10.1002/eji.201343606 · Cited by 77
Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment
Rashid, M. H., Borin, T. F., Ara, R., Piranlioglu, R., Achyut, B. R., Körkaya, H., Liu, Y., & Arbab, A. S. (2021) · Oncology Reports · doi:10.3892/or.2021.7936 · Cited by 77
Multifaceted role of chemokines in solid tumors: From biology to therapy
Raza, S., Rajak, S., Tewari, A., Gupta, P., Chattopadhyay, N., Sinha, R. A., & Chakravarti, B. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.12.011 · Cited by 79
The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
Ling, X., Spaeth, E. L., Chen, Y., Shi, Y., Zhang, W., Schober, W. D., Hail, N., Konopleva, M. Y., & Andreeff, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058426 · Cited by 78
Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis
Ye, X.-Z., Yu, S., & Bian, X. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60061-8 · Cited by 79
Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
Vahidian, F., Duijf, P. H. G., Safarzadeh, E., Derakhshani, A., Baghbanzadeh, A., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.004 · Cited by 75
Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
Grépin, R., & Pagès, G. (2010) · Journal of Oncology · doi:10.1155/2010/835680 · Cited by 76
ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells
Gallego‐Ortega, D., Ledger, A., Roden, D. L., Law, A. M. K., Magenau, A., Kikhtyak, Z., Cho, C., Allerdice, S. L., Lee, H. J., Valdés‐Mora, F., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002330 · Cited by 73
Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
Lorenzo-Sanz, L., & Muñoz, P. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00232-2 · Cited by 76
HIF-α/MIF and NF-κB/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC
Zhu, G., Tang, Y., Geng, N., Zheng, M. H., Jiang, J. D., Li, L., Li, K., Lei, Z., Chen, W., Fan, Y., et al. (2014) · Neoplasia · doi:10.1593/neo.132034 · Cited by 74
Cancer-Associated Myeloproliferation: Old Association, New Therapeutic Target
Wilcox, R. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0077 · Cited by 74
Targeting stroma to treat cancers
Engels, B., Rowley, D. A., & Schreiber, H. W. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.008 · Cited by 77
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Rakaee, M., Busund, L., Paulsen, E., Richardsen, E. H., Al‐Saad, S., Andersen, S., Dønnem, T., Bremnes, R. M., & Kilvaer, T. K. (2016) · Oncotarget · doi:10.18632/oncotarget.12360 · Cited by 74
One microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 75
Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
Li, Z., Pang, Y., Gara, S. K., Achyut, B. R., Heger, C. D., Goldsmith, P. K., Lonning, S. M., & Yang, H. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27572 · Cited by 75
Carcinoma origin dictates differential skewing of monocyte function
Bögels, M., Braster, R., Nijland, P. G., Gül, N., van de Luijtgaarden, W., Fijneman, R. J. A., Meijer, G. A., Jiménez, C. R., Beelen, R. H. J., & van Egmond, M. (2012) · OncoImmunology · doi:10.4161/onci.20427 · Cited by 73
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Bujanda, Z. A. L., & Drake, C. G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5vmr1116-491rr · Cited by 74
Metastasis as a systemic disease: molecular insights and clinical implications
Alečković, M., McAllister, S. S., & Polyák, K. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.06.002 · Cited by 73
The Engagement Between MDSCs and Metastases: Partners in Crime
Trovato, R., Canè, S., Petrova, V., Sartoris, S., Ugel, S., & Sanctis, F. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00165 · Cited by 74
Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy
Bullock, K. K., & Richmond, A. J. (2021) · Cancers · doi:10.3390/cancers13246293 · Cited by 77
Self-citation
The emerging role of myeloid-derived suppressor cells in lung diseases
Kolahian, S., Öz, H. H., Zhou, B., Griessinger, C. M., Rieber, N. P., & Hartl, D. (2016) · European Respiratory Journal · doi:10.1183/13993003.01572-2015 · Cited by 74
Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact
Talmadge, J. E. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.002 · Cited by 74
Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma
Pang, X., Fan, H., Tang, Y., Wang, S., Cao, M., Wang, H., Dai, L., Wang, K., Yu, X., Wu, J., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229089 · Cited by 72
Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
Gallo, G., Vescio, G., Paola, G. D., & Sammarco, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112295 · Cited by 72
Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
Kuonen, F., Laurent, J., Secondini, C., Lorusso, G., Stehle, J., Rausch, T., Hull, E. F.-V., Bieler, G., Alghisi, G., Schwendener, R. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3028 · Cited by 70
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Chrétien, S., Zerdes, I., Bergh, J. C. S., Matikas, A., & Foukakis, T. (2019) · Cancers · doi:10.3390/cancers11050628 · Cited by 71
Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis
Cataisson, C., Ohman, R., Patel, G., Pearson, A., Tsien, M. Z., Jay, S., Wright, L. N., Hennings, H., & Yuspa, S. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2490 · Cited by 70
Krüppel-like factors in cancer progression: three fingers on the steering wheel
Limame, R., de Beeck, K. O., Lardon, F., de Wever, O., & Pauwels, P. (2013) · OncoTarget · doi:10.18632/oncotarget.1456 · Cited by 69
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Mazzone, M., & Bergers, G. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114721 · Cited by 70
Myeloid cells in cancer-related inflammation
Caronni, N., Savino, B., & Bonecchi, R. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.10.001 · Cited by 71
Increased circulating L in−/low CD 33+ HLA‐DR − myeloid‐derived suppressor cells in hepatocellular carcinoma patients
Shen, P., Wang, A., He, M., Wang, Q., & Zheng, S. (2013) · Hepatology Research · doi:10.1111/hepr.12167 · Cited by 67
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis
Ye, T., Wei, X., Yin, T., Xia, Y., Li, D., Shao, B., Song, X., He, S., Luo, M., Gao, X., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2829-y · Cited by 70
Emerging Therapeutic Targets in Breast Cancer Bone Metastasis
Rose, A. A. N., & Siegel, P. M. (2009) · Future Oncology · doi:10.2217/fon.09.138 · Cited by 68
Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy
Zhao, X., Yang, X., Wang, X., Zhao, X., Zhang, Y., Liu, S., Anderson, G. J., Kim, S.-J., Li, Y., & Nie, G. (2021) · ACS Nano · doi:10.1021/acsnano.0c08860 · Cited by 66
Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer
Hu, X., Bardhan, K., Paschall, A. V., Yang, D., Waller, J. L., Park, M. A., Nayak-Kapoor, A., Samuel, T. A., Abrams, S. I., & Liu, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.434530 · Cited by 68
Rgs2 Mediates Pro-Angiogenic Function of Myeloid Derived Suppressor Cells in the Tumor Microenvironment via Upregulation of MCP-1
Boelte, K. C., Gordy, L. E., Joyce, S., Thompson, M. A., Li, Y., & Lin, P. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018534 · Cited by 67
Self-citation
Inhibition of dendritic cell migration by transforming growth factor-β1 increases tumor-draining lymph node metastasis
Imai, K., Minamiya, Y., Koyota, S., Ito, M., Saito, H., Sato, Y., Motoyama, S., Sugiyama, T., & Ogawa, J. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-3 · Cited by 66
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
Weiss, J. M., Back, T. C., Scarzello, A. J., Subleski, J. J., Hall, V. L., Stauffer, J. K., Chen, X., Micić, D., Alderson, K. L., Murphy, W. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909474106 · Cited by 66
Stem cells in tumor angiogenesis
Fang, S., & Salvén, P. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.024 · Cited by 77
Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development
Kohanbash, G., & Okada, H. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.689591 · Cited by 65
TGFβ and cancer metastasis: an inflammation link
Yang, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9226-3 · Cited by 65
Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects
Luger, D., Yang, Y.-A., Raviv, A., Weinberg, D., Banerjee, S., Lee, M.-J., Trepel, J. B., Yang, H. H., & Wakefield, L. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076115 · Cited by 65
Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer
Ock, C.-Y., Nam, A., Lee, J., Bang, J., Lee, K.-H., Han, S., Kim, T. Y., Im, S., Kim, T.-Y., Bang, Y., et al. (2016) · Gastric Cancer · doi:10.1007/s10120-016-0613-5 · Cited by 65
Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy
Zhang, W., Li, J., Qi, G., Tu, G.-W., Yang, C., & Xu, M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1395-9 · Cited by 65
LIM and SH3 Protein -1 Modulates CXCR2-Mediated Cell Migration
Raman, D., Sai, J., Neel, N. F., Chew, C. S., & Richmond, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010050 · Cited by 65
Self-citation
Hampering Immune Suppressors
Albeituni, S., Ding, C., & Yan, J. (2013) · The Cancer Journal · doi:10.1097/ppo.0000000000000006 · Cited by 65
Myeloid cells in tumor inflammation
Schmid, M. C., & Varner, J. A. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-14 · Cited by 67
Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling
Liu, H., Ling, C. C., Yeung, W. H., Pang, L., Liu, J., Zhou, J., Zhang, W. Y., Liu, X. B., Ng, T., Yang, X. X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03788-4 · Cited by 64
Emerging roles of the tumor-associated stroma in promoting tumor metastasis
Horimoto, Y., Polanska, U. M., Takahashi, Y., & Orimo, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20631 · Cited by 65
A Critical Role for Transcription Factor Smad4 in T Cell Function that Is Independent of Transforming Growth Factor β Receptor Signaling
Gu, A.-D., Zhang, S., Wang, Y., Xiong, H., Curtis, T. A., & Wan, Y. Y. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.019 · Cited by 63
Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Chang, A., Schwertschkow, A., Nolta, J. A., & Wu, J. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150126154151 · Cited by 64
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
Cuesta‐Mateos, C., Alcaraz‐Serna, A., Somovilla-Crespo, B., & Muñoz‐Calleja, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01936 · Cited by 65
Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads
Marcucci, F., Bellone, M., Caserta, C. A., & Corti, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28572 · Cited by 64
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation
Pickup, M. W., Hover, L. D., Polikowsky, E. R., Chytil, A. M., Gorska, A. E., Novitskiy, S. V., Moses, H. L., & Owens, P. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.004 · Cited by 60
Self-citation
Myeloid-derived suppressor cells: A novel therapeutic target
Ko, J. S., Bukowski, R. M., & Finke, J. H. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0014-6 · Cited by 61
HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection
Li, W., Wu, K., Zhao, E., Shi, L., Li, R., Zhang, P., Yin, Y., Shuai, X., Wang, G., & Tao, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.109 · Cited by 61
Expression of Toll-Like Receptors on Breast Tumors: Taking a Toll on Tumor Microenvironment
Bhattacharya, D., & Yusuf, N. (2011) · International Journal of Breast Cancer · doi:10.1155/2012/716564 · Cited by 63
Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model
Argast, G. M., Krueger, J. S., Thomson, S., Sujka-Kwok, I., Carey, K., Silva, S., O’Connor, M., Mercado, P., Mulford, I. J., Young, G. D., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9394-8 · Cited by 61
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor MicroenvironmentPreprint
Pickup, M. W., Owens, P., & Moses, H. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022285 · Cited by 63
Self-citation
Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities
Bashash, D., Zandi, Z., Kashani, B., Pourbagheri‐Sigaroodi, A., Salari, S., & Ghaffari, S. H. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30575 · Cited by 62
Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model
Takahashi, M., Miyazaki, H., Furihata, M., Sakai, H., Konakahara, T., Watanabe, M., & Okada, T. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9281-8 · Cited by 60
The role of inflammation in progression of breast cancer: Friend or foe? (Review)
Allen, M. D., & Jones, J. L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3075 · Cited by 60
CXCL5-mediated accumulation of mature neutrophils in lung cancer tissues impairs the differentiation program of anticancer CD8 T cells and limits the efficacy of checkpoint inhibitors
Simoncello, F., Piperno, G. M., Caronni, N., Amadio, R., Cappelletto, A., Canarutto, G., Piazza, S., Bicciato, S., & Benvenuti, F. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2059876 · Cited by 58
Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis
Li, Y., Li, M., Su, K., Zong, S., Zhang, H., & Xiong, L. (2023) · Theranostics · doi:10.7150/thno.82700 · Cited by 61

Authors: Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
Affiliations: Vanderbilt University (US)
Corresponding author: Moses, Harold L.
ORCID: Huang, Jianhua
Ren, Xiubao
Gorska, Agnieszka E.
Carbone, David P.
Matrisian, Lynn M.
Richmond, Ann
Moses, Harold L.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2008-01
Volume: 13
Issue: 1
Pages: 23-35
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.12.004
PMC: PMC2245859
OpenAlex: W2130870648
Cited by: 918
References: 61
Citations by year: 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
FWCI: 29.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2024 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK6 BX005225)
Vanderbilt University
National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords: TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks